Mathematical modeling insights into improving CAR T cell therapy for solid tumors with bystander effects

Area of Science:

• Immunology
• Computational Biology
• Oncology

Background:

• Chimeric Antigen Receptor T cell (CAR T cell) therapy is effective against blood cancers but limited in solid tumors.
• Solid tumors present challenges like antigen heterogeneity and poor T cell infiltration, hindering CAR T cell efficacy.
• Antigen spreading, a potential bystander effect where CAR T cells activate endogenous T cells against non-targeted antigens, is crucial for solid tumor treatment.

Purpose of the Study:

• To develop a mathematical model of CAR T cell therapy for solid tumors incorporating antigen heterogeneity and bystander effects.
• To investigate the relationship between bystander killing and CAR T cell therapy efficacy in solid tumors.
• To explore strategies for enhancing bystander effects to improve CAR T cell therapy outcomes.

Main Methods:

• Development of a mathematical model simulating CAR T cell therapy in solid tumors.
• Inclusion of in vivo treatment data with mixed target antigen-positive and -negative tumor cells.
• Simulation of large virtual patient cohorts to analyze bystander killing dynamics.

Main Results:

• The model provides insights into the relationship between bystander killing and CAR T cell therapy effectiveness.
• Simulations help understand how antigen heterogeneity impacts treatment outcomes.
• Identified potential strategies to enhance bystander effects for improved solid tumor therapy.

Conclusions:

• CAR T cell therapy for solid tumors can be enhanced by leveraging bystander effects and addressing antigen heterogeneity.
• Mathematical modeling is a valuable tool for understanding complex biological processes in cancer therapy.
• Further research into strategies that promote antigen spreading could significantly improve CAR T cell efficacy in solid tumors.